Trainee Day - Saturday, March 19, 10:00 - 13:00 CET, Virtual Hall 5
This year’s varied Trainee Day program is divided across two sessions, one focusing on the functioning of EBMT as it relates to trainees and the second with specific sessions related to transplantation training.
The first talk will be given by EBMT Trainee co-chairs Claire Horgan (UK) and Nico Gagelmann (Germany), titled ‘The First Year of the EBMT Trainee Committee’. Claire is Clinical research fellow in Paediatric BMT, CAR-T and Stem Cell Gene Therapy, Manchester University NHS Foundation Trust, UK, while Nico is a Physician at University Medical Center Hamburg-Eppendorf, Germany.
The two co-chairs will together discuss the first year of the EBMT Committee from being officially established in January 2021 right up to this year's congress, now fully online again due to the ongoing Ukraine crisis. They will highlight several of the group's activities over this time, including integrated trainee-focused content and sessions at international conferences, to educational resources such as the free to access e-learning course 'Chimera', and the podcast platforms, 'The Graft' and 'Trainee Pearls'. As part of the session, they will also deliver the results of the EBMT Trainee Committee Survey, highlighting the vast discrepancies in access and experience in BMT and Cellular therapy exposure amongst trainees worldwide.
Claire says: "We're really pleased to be able to deliver the first official EBMT Trainee Day at this year's annual congress and hope that it will become an established event for the future, enabling trainees to network and collaborate across and beyond the EBMT community. The dedicated trainee day highlights the important role that trainees have within EBMT, as well as delivering important guidance including practical tips for managing complex transplant complications and advice for building a career within the field."
Following this, Dr Silvy Lachance, Director of the Hematopoietic Cell Transplantation and Cellular Therapy Fellowship Program and Professor of Medicine at the University of Montreal, Québec, Canada, will discuss Canada’s trailblazing “Cell Transplantation and Cellular Therapy Fellowship Program”.
Haematopoietic stem cell transplantation (HSCT) and cellular therapy (CT) exploit the therapeutic potential of manipulated or unmanipulated haematopoietic cells to treat diseases. While initially dedicated to the treatment of haematological malignancies and disorders, its efficacy is currently being investigated in several diseases and cancers.
“Indications are currently booming,” explains Professor Lachance. “In the midst of this expansion, both the American Society for Transplantation and Cellular Therapy (ASTCT) and European Society for Blood and Marrow Transplantation (EBMT) have highlighted the global shortage of haematologists adequately trained in this field of high expertise. This shortage in transplanters and cellular therapists can significantly impact patient access to cell-based therapy.”
To address this unmet need, attract aspiring haematologists to the field of cellular therapy and to standardise training, the Royal College of Physicians and Surgeons of Canada created a structured academic program in HSCT and CT and recognised this as an area of focus competencies. “My conference presentation will summarise the building blocks of the accredited curriculum developed in Canada and how to choose wisely a training program in HSCT and CT,” concludes Professor Lachance.
Other talks in the Trainee Day will include one on “CAR T toxicity for trainees” by Claire Roddie, Assistant Professor in Haematology at University College London, UK, and ‘The nurse-doctor team in transplant’, given by both Nico Gagelmann and EBMT Nurses Group Immediate Past President John Murray.